155 related articles for article (PubMed ID: 22404155)
1. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation.
Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M
Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells.
Alotaibi M; Sharma K; Saleh T; Povirk LF; Hendrickson EA; Gewirtz DA
Radiat Res; 2016 Mar; 185(3):229-45. PubMed ID: 26934368
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation.
Lesueur P; Chevalier F; El-Habr EA; Junier MP; Chneiweiss H; Castera L; Müller E; Stefan D; Saintigny Y
Sci Rep; 2018 Feb; 8(1):3664. PubMed ID: 29483558
[TBL] [Abstract][Full Text] [Related]
4. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation.
Mao Y; Huang X; Shuang Z; Lin G; Wang J; Duan F; Chen J; Li S
Cancer Med; 2018 Apr; 7(4):1285-1296. PubMed ID: 29479816
[TBL] [Abstract][Full Text] [Related]
6. Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1.
Vodenicharov MD; Sallmann FR; Satoh MS; Poirier GG
Nucleic Acids Res; 2000 Oct; 28(20):3887-96. PubMed ID: 11024167
[TBL] [Abstract][Full Text] [Related]
7. Participation of gap junction communication in potentially lethal damage repair and DNA damage in human fibroblasts exposed to low- or high-LET radiation.
Autsavapromporn N; Suzuki M; Plante I; Liu C; Uchihori Y; Hei TK; Azzam EI; Murakami T
Mutat Res; 2013 Aug; 756(1-2):78-85. PubMed ID: 23867854
[TBL] [Abstract][Full Text] [Related]
8. Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.
Farrés J; Martín-Caballero J; Martínez C; Lozano JJ; Llacuna L; Ampurdanés C; Ruiz-Herguido C; Dantzer F; Schreiber V; Villunger A; Bigas A; Yélamos J
Blood; 2013 Jul; 122(1):44-54. PubMed ID: 23678004
[TBL] [Abstract][Full Text] [Related]
9.
Molenaar RJ; Radivoyevitch T; Nagata Y; Khurshed M; Przychodzen B; Makishima H; Xu M; Bleeker FE; Wilmink JW; Carraway HE; Mukherjee S; Sekeres MA; van Noorden CJF; Maciejewski JP
Clin Cancer Res; 2018 Apr; 24(7):1705-1715. PubMed ID: 29339439
[No Abstract] [Full Text] [Related]
10. Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.
Znojek P; Willmore E; Curtin NJ
Br J Cancer; 2014 Sep; 111(7):1319-26. PubMed ID: 25003660
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin as a potential radio-sensitizer to tumor cells and a radio-protectant for normal cells: differential effects on γ-H2AX formation, p53 phosphorylation, Bcl-2 production, and cell death.
Kiang JG; Garrison BR; Smith JT; Fukumoto R
Mol Cell Biochem; 2014 Aug; 393(1-2):133-43. PubMed ID: 24802382
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation.
Srivastava P; Sarma A; Chaturvedi CM
PLoS One; 2018; 13(1):e0190516. PubMed ID: 29320576
[TBL] [Abstract][Full Text] [Related]
13. High LET radiation enhances apoptosis in mutated p53 cancer cells through Caspase-9 activation.
Yamakawa N; Takahashi A; Mori E; Imai Y; Furusawa Y; Ohnishi K; Kirita T; Ohnishi T
Cancer Sci; 2008 Jul; 99(7):1455-60. PubMed ID: 18422753
[TBL] [Abstract][Full Text] [Related]
14. A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.
Chen H; Zeng X; Gao C; Ming P; Zhang J; Guo C; Zhou L; Lu Y; Wang L; Huang L; He X; Mei L
Sci Rep; 2015 Jun; 5():10893. PubMed ID: 26041102
[TBL] [Abstract][Full Text] [Related]
15. A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers.
Alruwaili MM; Zonneville J; Naranjo MN; Serio H; Melendy T; Straubinger RM; Gillard B; Foster BA; Rajan P; Attwood K; Chatley S; Iyer R; Fountzilas C; Bakin AV
Cell Rep Med; 2024 Mar; 5(3):101434. PubMed ID: 38387463
[TBL] [Abstract][Full Text] [Related]
16. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons.
Bright SJ; Flint DB; Martinus DKJ; Turner BX; Manandhar M; Ben Kacem M; McFadden CH; Yap TA; Shaitelman SF; Sawakuchi GO
Radiat Res; 2022 Oct; 198(4):336-346. PubMed ID: 35939823
[TBL] [Abstract][Full Text] [Related]
17. Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
Park S; Choi C; Kim H; Shin YJ; Oh Y; Park W; Cho WK; Kim N
Breast Cancer Res Treat; 2024 Feb; 203(3):449-461. PubMed ID: 37902934
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.
Dong M; Luo H; Liu R; Zhang J; Yang Z; Wang D; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
J Cancer; 2024; 15(3):699-713. PubMed ID: 38213724
[No Abstract] [Full Text] [Related]
19. β-D-Glucan promotes NF-κB activation and ameliorates high-LET carbon-ion irradiation-induced human umbilical vein endothelial cell injury.
Liu F; Wei Y; Wang Z
Turk J Med Sci; 2023; 53(6):1621-1634. PubMed ID: 38813508
[TBL] [Abstract][Full Text] [Related]
20. PARP inhibitors target ATM+p53-defective gastric cancer.
Curtin NJ
Cell Cycle; 2014; 13(20):3161-2. PubMed ID: 25485492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
